Supplement Article January 1, 2004

Guideline 16: Combining Medications in Older Patients

J Clin Psychiatry 2004;65(suppl 2):40-40

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The experts recommended close monitoring for side effects when using the combinations listed in the table below. More than a quarter of the experts considered the following combinations to be contraindicated: clozapine + carbamazepine (rated as contraindicated by 39% of the experts), ziprasidone + a tricyclic antidepressant (TCA) (rated as contraindicated by 26%), and a low-potency conventional antipsychotic + fluoxetine (rated as contraindicated by 27%). Certain combinations of medications caused the experts more concern (e.g., drugs that are potent inhibitors of CYP drug-metabolizing enzymes and thus have increased potential to cause drug-drug interactions).’ ‹